- Recognized as a leader in the 'Gentle Power' trend for its DA500 Barrier Protection Sun Cream, developed from over 1 million clinical cases. - Company announces strategic expansion into the U.S. market with a new subsidiary and upcoming FDA-compliant OTC sunscreen lines.
MIAMI, Feb. 11, 2026 /PRNewswire-PRWeb/ -- ADP-Derma Inc., a specialist in clinical dermatological solutions, announced today that its skincare brand, ALADDIN RX, has been selected for the prestigious 'Cosmo Trends 2026' report at Cosmoprof North America Miami, the leading B2B beauty trade show in the Americas.
Source: Cosmoprof North America Miami 2026
The Cosmo Trends report, curated by the global trend authority BEAUTYSTREAMS, serves as the definitive guide to the most innovative products at the exhibition. ALADDIN RX's 'DA500 Barrier Protection Sun Cream' was spotlighted in the 'Gentle Power' category, a trend emphasizing high-efficacy, low-irritation solutions designed for sensitive skin in urban environments.
This recognition highlights ALADDIN RX's unique heritage in medical aesthetics. Evolution of the professional 'Aladdin Peeling' treatment—which has recorded over 1 million clinical procedures—the brand has integrated proven recovery mechanisms into consumer skincare.
The DA500 Sun Cream targets the 'Golden Hour,' the critical recovery window immediately following professional skin treatments when the skin barrier is most vulnerable. BEAUTYSTREAMS praised the product's 'DA500' technology, which utilizes active ingredients with a molecular weight over 500 Daltons. This formulation minimizes dermal absorption to significantly reduce irritation while providing robust protection on the skin's surface.
"We are honored to see ALADDIN RX recognized in the Cosmo Trends report," said Will Shin, a representative for ADP-Derma. "This selection validates our commitment to authentic skin science. We focus on delivering results proven in clinical fields rather than relying on marketing hype. We aim to become the top-of-mind brand for skin recovery globally."
Following this recognition, ADP-Derma is set to accelerate its expansion into the North American market. With the establishment of a U.S. subsidiary in early 2026, the company plans to secure local distribution channels and introduce new product lines. This includes the development of Over-the-Counter (OTC) sunscreens tailored to U.S. FDA standards and local consumer preferences.
[Reference: Product Information]
- Product Name: ALADDIN RX DA500 Barrier Protection Sun Cream
- Core Value: Built on the expertise of 1 million Aladdin Peeling procedures; specialized care for the post-procedure 'Golden Hour.'
- Technical Features: High molecular weight (over 500 Daltons) design to minimize irritation; Hybrid UV protection system.
- Key Ingredients: Panthenol, Allantoin, Niacinamide, Adenosine, Carnosine, Ceramide NP.
[Media Inquiry]
- ADP-Derma PR Team: Will Shin ([email protected])
- Homepage: https://www.aladdinrx.com
Media Contact
Will Shin, ADP-Derma Inc., 82 (0)2-6956-8070, [email protected], https://www.aladdinrx.com
SOURCE ADP-Derma Inc.
Share this article